CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-04 | Bancel Stephane Chief Executive Officer | Sale | −2,212 | $180.16 | $399K | 5,411,946 |
| 2023-01-04 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 1,987,155 | ||
| 2023-01-04 | AFEYAN NOUBAR Director | Sale | −10,000 | $182.15 | $1.8M | 2,267,209 |
| 2022-12-29 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2022-12-29 | Bancel Stephane Chief Executive Officer | Sale | −20,708 | $179.31 | $3.7M | 5,431,238 |
| 2022-12-29 | Bancel Stephane Chief Executive Officer | Sale | −15,890 | $180.25 | $2.9M | 5,415,348 |
| 2022-12-29 | Bancel Stephane Chief Executive Officer | Sale | −2,602 | $181.07 | $471K | 5,412,746 |
| 2022-12-29 | Bancel Stephane Chief Executive Officer | Sale | −800 | $182.13 | $146K | 5,411,946 |
| 2022-12-29 | Bancel Stephane Chief Executive Officer | Sale | −10,000 | $178.19 | $1.8M | 6,564,880 |
| 2022-12-29 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 2,027,155 | ||
| 2022-12-28 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2022-12-28 | Bancel Stephane Chief Executive Officer | Sale | −4,423 | $175.37 | $776K | 5,447,523 |
| 2022-12-28 | Bancel Stephane Chief Executive Officer | Sale | −15,728 | $176.33 | $2.8M | 5,431,795 |
| 2022-12-28 | Bancel Stephane Chief Executive Officer | Sale | −8,639 | $177.00 | $1.5M | 5,423,156 |
| 2022-12-28 | Bancel Stephane Chief Executive Officer | Sale | −8,926 | $178.46 | $1.6M | 5,414,230 |
| 2022-12-28 | Bancel Stephane Chief Executive Officer | Sale | −2,284 | $178.96 | $409K | 5,411,946 |
| 2022-12-28 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 2,067,155 | ||
| 2022-12-28 | Andres Juan | Exercise or conversion | +2,000 | $20.93 | $42K | 14,803 |
| 2022-12-28 | Andres Juan | Sale | −2,000 | $180.00 | $360K | 12,803 |
| 2022-12-28 | Andres Juan | Exercise or conversion · Stock Option (Right to Buy) | −2,000 | 203,025 |
Page 62 of 66 · 1,314 trades